Tria Williams
Tria Williams
Details
Role
Senior Clinical Trials Manager
Research area
Infection, Immunity and Global Health
Group
Vaccine Uptake
Contact
Email
show email address
Tria Williams is the Research Manager of the Vaccine and Immunisation Research Group (VIRGo). With over 25 years of experience as a paediatric nurse, she has worked at both the Royal Children's Hospital and the Murdoch Children’s Research Institute. Tria holds a Master of Clinical Research from the University of Melbourne.
The primary goal of VIRGo is to improve children's health in Victoria and across Australia by protecting them from vaccine-preventable diseases. Tria focuses on establishing a collaborative, coordinated, best-practice, paediatric-centred approach to vaccine clinical trials in Victoria. This is achieved by raising awareness of the importance of childhood immunisation and facilitating access to new vaccines through a specialised, coordinated approach to delivering vaccine clinical trials.
During the 2020/21 pandemic, Tria contributed to the Tropical Diseases and Vaccine Uptake groups, including the COVID Wellbeing and Schools project. She also led the Urban Pharyngitis Surveillance Study as part of the Australian Strep A Vaccine Initiative (ASAVI), a global effort to reduce the disease burden caused by Strep A infections through effective vaccination. In recognition of her dedication to patient care, Tria received the Royal Children’s Hospital Mary Patten Award in 2007.
The primary goal of VIRGo is to improve children's health in Victoria and across Australia by protecting them from vaccine-preventable diseases. Tria focuses on establishing a collaborative, coordinated, best-practice, paediatric-centred approach to vaccine clinical trials in Victoria. This is achieved by raising awareness of the importance of childhood immunisation and facilitating access to new vaccines through a specialised, coordinated approach to delivering vaccine clinical trials.
During the 2020/21 pandemic, Tria contributed to the Tropical Diseases and Vaccine Uptake groups, including the COVID Wellbeing and Schools project. She also led the Urban Pharyngitis Surveillance Study as part of the Australian Strep A Vaccine Initiative (ASAVI), a global effort to reduce the disease burden caused by Strep A infections through effective vaccination. In recognition of her dedication to patient care, Tria received the Royal Children’s Hospital Mary Patten Award in 2007.
Tria Williams is the Research Manager of the Vaccine and Immunisation Research Group (VIRGo). With over 25 years of experience as a paediatric nurse, she has worked at both the Royal Children's Hospital and the Murdoch Children’s Research Institute....
Tria Williams is the Research Manager of the Vaccine and Immunisation Research Group (VIRGo). With over 25 years of experience as a paediatric nurse, she has worked at both the Royal Children's Hospital and the Murdoch Children’s Research Institute. Tria holds a Master of Clinical Research from the University of Melbourne.
The primary goal of VIRGo is to improve children's health in Victoria and across Australia by protecting them from vaccine-preventable diseases. Tria focuses on establishing a collaborative, coordinated, best-practice, paediatric-centred approach to vaccine clinical trials in Victoria. This is achieved by raising awareness of the importance of childhood immunisation and facilitating access to new vaccines through a specialised, coordinated approach to delivering vaccine clinical trials.
During the 2020/21 pandemic, Tria contributed to the Tropical Diseases and Vaccine Uptake groups, including the COVID Wellbeing and Schools project. She also led the Urban Pharyngitis Surveillance Study as part of the Australian Strep A Vaccine Initiative (ASAVI), a global effort to reduce the disease burden caused by Strep A infections through effective vaccination. In recognition of her dedication to patient care, Tria received the Royal Children’s Hospital Mary Patten Award in 2007.
The primary goal of VIRGo is to improve children's health in Victoria and across Australia by protecting them from vaccine-preventable diseases. Tria focuses on establishing a collaborative, coordinated, best-practice, paediatric-centred approach to vaccine clinical trials in Victoria. This is achieved by raising awareness of the importance of childhood immunisation and facilitating access to new vaccines through a specialised, coordinated approach to delivering vaccine clinical trials.
During the 2020/21 pandemic, Tria contributed to the Tropical Diseases and Vaccine Uptake groups, including the COVID Wellbeing and Schools project. She also led the Urban Pharyngitis Surveillance Study as part of the Australian Strep A Vaccine Initiative (ASAVI), a global effort to reduce the disease burden caused by Strep A infections through effective vaccination. In recognition of her dedication to patient care, Tria received the Royal Children’s Hospital Mary Patten Award in 2007.
Top Publications
- Brusco, NK, Danchin, M, Watts, JJ, Jos, C, Loughnan, M, Williams, T, Ratcliffe, J, Hoq, M, Tosif, S, Kaufman, J. Parent-Reported Child and Parent Quality of Life during COVID-19 Testing at an Australian Paediatric Hospital Outpatient Clinic: A Cross-Sectional Study.. Healthcare (Basel) 11(18) : 2023 view publication
- Kaufman, J, Bagot, KL, Williams, T, Jos, C, Danchin, M. Exploring the lived experience of families with a COVID-19 positive child: The journey from a critical grounded theory approach.. PLoS One 18(3) : e0282481 2023 view publication
- McCarthy, MC, Beamish, J, Bauld, CM, Marks, IR, Williams, T, Olsson, CA, De Luca, CR. Parent perceptions of pediatric oncology care during the COVID-19 pandemic: An Australian study.. Pediatr Blood Cancer 69(2) : e29400 2022 view publication
